ljc 10627 has been researched along with Critical Illness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiue, Y; Ikawa, K; Ikeda, K; Kaneko, K; Kuwabara, M; Morikawa, N; Morikawa, S; Suyama, H; Yamanoue, T | 1 |
| Ikawa, K; Ikeda, K; Morikawa, N; Suyama, H | 1 |
1 trial(s) available for ljc 10627 and Critical Illness
| Article | Year |
|---|---|
Pharmacokinetic modeling and dosage adaptation of biapenem in Japanese patients during continuous venovenous hemodiafiltration.
Topics: Acute Kidney Injury; Aged; Anti-Infective Agents; Area Under Curve; Chromatography, High Pressure Liquid; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Routes; Female; Hemofiltration; Humans; Infections; Japan; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Predictive Value of Tests; Prospective Studies; Thienamycins | 2008 |
1 other study(ies) available for ljc 10627 and Critical Illness
| Article | Year |
|---|---|
Pharmacokinetics and pharmacodynamics of biapenem in critically ill patients under continuous venovenous hemodiafiltration.
Topics: Acute Kidney Injury; Adult; Aged; Critical Illness; Drosophila Proteins; Drug Resistance, Bacterial; Female; Hemodiafiltration; Humans; Infusions, Intravenous; Male; Middle Aged; Monte Carlo Method; Nerve Tissue Proteins; Nuclear Proteins; Pseudomonas aeruginosa; Sepsis; Therapeutic Equivalency; Thienamycins; Time Factors; Transcription Factors | 2008 |